Tilray Brands (TLRY)
(Delayed Data from NSDQ)
$2.10 USD
+0.08 (3.96%)
Updated May 3, 2024 04:00 PM ET
After-Market: $2.09 -0.01 (-0.48%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Brokerage Reports
0 items in cart
Tilray Brands, Inc. [TLRY]
Reports for Purchase
Showing records 141 - 160 ( 219 total )
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Canadian LPs: Mixed Outlook with Regulatory, Limited Retail, and 2.0 Overhangs
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Canada Industry Overhangs Continue, Lowering Estimates and Outlook
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Receives GMP Certification at EU Campus, Allows for International Export
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
3Q19 Strong Revenue Results, Nearing an Inflection
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S